Bi
Bio-Manguinhos
Rio de Janeiro BRFounded 19762,000 employees
Private CapgovPrivateInfectious Disease
Platform: Fiocruz Vaccines
Market Cap
N/A
All Drugs
5
Clinical Trials
5
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| BIO-IIT-877 | BIO-IIT-877 | Preclinical | 1 | AHR | SCLC | ||
| BIO-IIT-937 | BIO-IIT-937 | Preclinical | 1 | AuroraA | Myelofibrosis | ||
| BIO-IIT-463 | BIO-IIT-463 | Approved | 1 | Nectin-4 | Heart Failure | ||
| BIO-IIT-514 | BIO-IIT-514 | Phase 1/2 | 1 | FcRn | SMA | ||
| BIO-IIT-157 | BIO-IIT-157 | Phase 1 | 1 | VEGF | NB |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)